Abstract
Migraine is a widely prevalent, complex neurobiological disorder with headache as its primary manifestation, but also including a variety of neurologic symptoms and phenomena. Migraine affects all ages, geographies, and races and creates significant personal disability as well as personal and societal costs. Although past theories implied a primarily vascular nature to the headaches, recent understanding of the pathology of migraine includes recognition of cortical and subcortical activation, genetic predisposition, cranial nerve sensitization, and neurovascular inflammation. While migraine without aura is the most common form, a variety of other migraine conditions are recognized. Treatment options for these conditions are expanding, including pharmacological and behavioral therapies, both to prevent the attacks and to abort them.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, on behalf of the AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.
Ferrari MD, Dichgans M. Genetics of primary headaches. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff’s headache and other head pain. 8th ed. New York: Oxford University Press; 2008.
Lipton RB, Scher AI, Silberstein SD, Bigal ME. Migraine diagnosis and comorbidity. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff’s headache and other head pain. 8th ed. New York: Oxford University Press; 2008.
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, on behalf of the AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–9.
Health statistics and information systems – regional estimates for 2000–2011. [internet] 2014. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index1.html.
Smitherman TA, Burch R, Sheikh J, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53:427–36.
Charles A. The evolution of a migraine attack – a review of recent evidence. Headache. 2013;53(2):413–9.
Ward TN. Migraine diagnosis and pathophysiology. Contin Lifelong Learn Neurol. 2012;18(4):753–63.
Burstein R, Jakubowski M, Garcia-Nicas E, Kainz V, Bajwa Z, Hargreaves R, Becerra L, Borsook D. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol. 2010;68(1):81–91.
Headache Classification Committee of the International Headache Society. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808.
Tepper S. Medication overuse headache. Contin Lifelong Learn Neurol. 2012;18(4):807–22.
Silberstein S, Holland S, Freitag F. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337–45.
Rizzoli P. Acute and preventive treatment of migraine. Contin Lifelong Learn Neurol. 2012;18(4):764–82.
Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF, PREEMPT 2 Chronic Migraine Study Group. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804–14.
Nestoriuc Y, Martin A. Efficacy of biofeedback for migraine: a meta-analysis. Pain. 2007;128(1–2):111–27.
Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. US Headache Consortium. 2000. http://tools.aan.com/professionals/practice/pdfs/gl0089.pdf. Accessed by Jan 6, 2015.
Chopra R, Robert T, Watson D. Non-pharmacologic and pharmacologic prevention of episodic migraine and chronic daily headache. WV Med J. 2012;108(3):90–3.
Silberstein SD, Freitag FG, Bigal ME. Migraine treatment. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff’s headache and other head pain. 8th ed. New York: Oxford University Press; 2008.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Watson, D.B. (2015). Migraine Headache. In: Wetmore, S., Rubin, A. (eds) Vestibular Migraine. Springer, Cham. https://doi.org/10.1007/978-3-319-14550-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-14550-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-14549-5
Online ISBN: 978-3-319-14550-1
eBook Packages: MedicineMedicine (R0)